This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (173)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Cervical Cancer  • Dermatology  • Papillomavirus, Human  • Alert me on articles by topic

Thomas C. Wright, Jr, MD; Lynette Denny, MMED, FCOG; Louise Kuhn, PhD; Amy Pollack, MD; Attila Lorincz, PhD

JAMA. 2000;283:81-86.

Context  More than half of the women diagnosed as having cervical cancer in the United States have not been screened within the last 3 years, despite many having had contact with the health care system. In many other regions of the world, there is only limited access to cervical cancer screening.

Objective  To determine whether testing of self-collected vaginal swabs for human papillomavirus (HPV) DNA can be used to screen for cervical disease in women aged 35 years and older.

Design  Cross-sectional observational study comparing Papanicolaou smears with HPV DNA testing of self-collected vaginal swabs.

Setting  Outpatient clinics in a periurban settlement outside of Cape Town, South Africa, between January 1998 and April 1999.

Participants  Screening was performed on 1415 previously unscreened black South African women aged 35 to 65 years.

Intervention  Women self-collected a vaginal swab for HPV testing in the clinic and were then screened using 4 different tests: Papanicolaou smear, direct visual inspection of the cervix after the application of 5% acetic acid, cervicography, and HPV DNA testing of a clinician-obtained cervical sample. Women with abnormal results on any of the screening tests were referred for colposcopy.

Main Outcome Measure  Biopsy-confirmed high-grade cervical squamous intraepithelial lesions or invasive cancer.

Results  High-grade squamous intraepithelial lesions were identified in 47 (3.4%) of 1365 women adequately assessed, and there were 9 cases of invasive cancer. Of women with high-grade disease, 66.1% (95% confidence interval [CI], 52.1%-77.8%) had high-risk HPV detected in self-collected vaginal samples, and 67.9% (95% CI, 53.9%-79.4%) had an abnormal Papanicolaou smear (P = .78). The false-positive rates for HPV DNA testing of self-collected vaginal samples and Papanicolaou smears were 17.1% (95% CI, 15.1%-19.3%) and 12.3% (95% CI, 10.5%-14.2%), respectively (P<.001). A high-risk type of HPV DNA was detected in 83.9% (95% CI, 71.2%-91.9%) of women with high-grade disease and 15.5% (95% CI, 13.6%-17.7%) of women with no evidence of cervical disease using a clinician-obtained cervical sample.

Conclusions  These results indicate that HPV testing of self-collected vaginal swabs is less specific than but as sensitive as Papanicolaou smears for detecting high-grade cervical disease in women aged 35 years and older, and HPV testing offers an important new way to increase screening in settings where cytology is not readily performed.

Author Affiliations: Department of Pathology, College of Physicians and Surgeons (Dr Wright) and Gertrude H. Sergievsky Center and Division of Epidemiology (Dr Kuhn), Columbia University and AVSC International (Dr Pollack), New York, NY; Department of Obstetrics and Gynecology, University of Cape Town, Cape Town, South Africa (Dr Denny); and Digene Corporation, Beltsville, Md (Dr Lorincz).

RELATED LETTERS

Human Papillomavirus Detection to Screen for Cervical Cancer
Marsham Moselhi, Thomas C. Wright, Jr, Louise Kuhn, and Lynette Denny
JAMA. 2000;284(1):39-40.
EXTRACT | FULL TEXT  

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Jeanne S. Mandelblatt, William F. Lawrence, Sharita Mizell Womack, Denise Jacobson, Bin Yi, Yi-ting Hwang, Karen Gold, James Barter, and Keerti Shah
JAMA. 2002;287(18):2372-2381.
ABSTRACT | FULL TEXT  

RELATED ARTICLES

Human Papillomavirus Testing for Primary Cervical Cancer Screening
Jack Cuzick
JAMA. 2000;283(1):108-109.
EXTRACT | FULL TEXT  

January 5, 2000
JAMA. 2000;283(1):137-138.
EXTRACT | FULL TEXT  

HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica
Mark Schiffman, Rolando Herrero, Allan Hildesheim, Mark E. Sherman, Maria Bratti, Sholom Wacholder, Mario Alfaro, Martha Hutchinson, Jorge Morales, Mitchell D. Greenberg, and Attila T. Lorincz
JAMA. 2000;283(1):87-93.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Self-Sampling for Human Papillomavirus in a Community Setting: Feasibility in Hispanic Women
De Alba et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2163-2168.
ABSTRACT | FULL TEXT  

Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda
Safaeian et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1300-1307.
ABSTRACT | FULL TEXT  

Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Patients with Cervical Neoplasia
Feng et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1178-1184.
ABSTRACT | FULL TEXT  

Agreement between Self- and Clinician-Collected Specimen Results for Detection and Typing of High-Risk Human Papillomavirus in Specimens from Women in Gugulethu, South Africa
Jones et al.
J. Clin. Microbiol. 2007;45:1679-1683.
ABSTRACT | FULL TEXT  

Vaginal self sampling versus physician cervical sampling for HPV among younger and older women.
Karwalajtys et al.
Sex. Transm. Infect. 2006;82:337-339.
ABSTRACT | FULL TEXT  

High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.
Brink et al.
J. Clin. Microbiol. 2006;44:2518-2523.
ABSTRACT | FULL TEXT  

Comparative accuracy: assessing new tests against existing diagnostic pathways.
Bossuyt et al.
BMJ 2006;332:1089-1092.
FULL TEXT  

Systems Analysis of Real-World Obstacles to Successful Cervical Cancer Prevention in Developing Countries
Suba et al.
Am. J. Public Health 2006;96:480-487.
ABSTRACT | FULL TEXT  

Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women
Shew et al.
Arch Pediatr Adolesc Med 2006;160:151-156.
ABSTRACT | FULL TEXT  

Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings: A Randomized Controlled Trial
Denny et al.
JAMA 2005;294:2173-2181.
ABSTRACT | FULL TEXT  

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis
Ogilvie et al.
Sex. Transm. Infect. 2005;81:207-212.
ABSTRACT | FULL TEXT  

Self-testing for human papillomavirus using a vaginal swab: placing prevention of cervical cancer in the patient's hands
Kahn
Ann Oncol 2004;15:847-849.
FULL TEXT  

Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics
Dannecker et al.
Ann Oncol 2004;15:863-869.
ABSTRACT | FULL TEXT  

HPV in cervix and vagina
Baay et al.
Sex. Transm. Infect. 2004;80:249-250.
FULL TEXT  

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie et al.
JNCI J Natl Cancer Inst 2004;96:604-615.
ABSTRACT | FULL TEXT  

Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus
Li et al.
J. Clin. Microbiol. 2003;41:5563-5571.
ABSTRACT | FULL TEXT  

Factors Affecting the Detection Rate of Human Papillomavirus
Harper et al.
Ann Fam Med 2003;1:221-227.
ABSTRACT | FULL TEXT  

Chapter 11: Future Directions in Cervical Pathology
Sherman
J Natl Cancer Inst Monogr 2003;2003:72-79.
ABSTRACT | FULL TEXT  

Chapter 12: Human Papillomavirus Technologies
Iftner and Villa
J Natl Cancer Inst Monogr 2003;2003:80-88.
ABSTRACT | FULL TEXT  

Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
Franco
J Natl Cancer Inst Monogr 2003;2003:89-96.
ABSTRACT | FULL TEXT  

Chapter 14: Role of Triage Testing in Cervical Cancer Screening
Solomon
J Natl Cancer Inst Monogr 2003;2003:97-101.
ABSTRACT | FULL TEXT  

Human Papillomavirus and Cervical Cancer
Burd
Clin. Microbiol. Rev. 2003;16:1-17.
ABSTRACT | FULL TEXT  

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow et al.
CA Cancer J Clin 2002;52:342-362.
ABSTRACT | FULL TEXT  

Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries
Mandelblatt et al.
JNCI J Natl Cancer Inst 2002;94:1469-1483.
ABSTRACT | FULL TEXT  

Self testing for human papillomaviruses
Herrington
J. Clin. Pathol. 2002;55:408-409.
FULL TEXT  

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women
Nobbenhuis et al.
J. Clin. Pathol. 2002;55:435-439.
ABSTRACT | FULL TEXT  

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt et al.
JAMA 2002;287:2372-2381.
ABSTRACT | FULL TEXT  

The causal relation between human papillomavirus and cervical cancer
Bosch et al.
J. Clin. Pathol. 2002;55:244-265.
ABSTRACT | FULL TEXT  

Diagnosis of human papillomavirus infection by dry vaginal swabs in military women
Shah et al.
Sex. Transm. Infect. 2001;77:260-264.
ABSTRACT | FULL TEXT  

Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings: Clinical Benefits and Cost-effectiveness
Goldie et al.
JAMA 2001;285:3107-3115.
ABSTRACT | FULL TEXT  

Recent advances: Sexually transmitted infections
Gilson and Mindel
BMJ 2001;322:1160-1164.
FULL TEXT  

Screening for Cervical Cancer
Wright Jr. et al.
Science 2000;290:1651a-1651.
FULL TEXT  

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions
Sellors et al.
CMAJ 2000;163:513-518.
ABSTRACT | FULL TEXT  

Human Papillomavirus Detection to Screen for Cervical Cancer
Moselhi et al.
JAMA 2000;284:39-40.
FULL TEXT  

Emerging Technologies and Cervical Cancer
Follen and Richards-Kortum
JNCI J Natl Cancer Inst 2000;92:363-365.
FULL TEXT  

Testing Self-Collected Vaginal Samples for HPV DNA to Detect Cervical Cancer
JWatch General 2000;2000:3-3.
FULL TEXT  

Human Papillomavirus Testing: Replacement for Pap Smear?
JWatch Infect. Diseases 2000;2000:3-3.
FULL TEXT  

Human Papillomavirus Testing for Primary Cervical Cancer Screening
Cuzick
JAMA 2000;283:108-109.
FULL TEXT